INS and Hypertension: The predictive value of proinsulin for the risk of developing T2D compared to insulin and C-peptide is currently unknown, and, to the best of our knowledge, there are no longitudinal studies investigating proinsulin level as a marker of incident T2D in participants with hypertension or kidney dysfunction.